SHP2-interacting_JJ
transmembrane_JJ
adaptor_NN
protein_NN
-LRB-_-LRB-
SIT_NN
-RRB-_-RRB-
,_,
a_DT
novel_JJ
disulfide-linked_JJ
dimer_NN
regulating_VBG
human_JJ
T_NN
cell_NN
activation_NN
._.

T_NN
lymphocytes_NNS
express_VBP
several_JJ
low_JJ
molecular_JJ
weight_NN
transmembrane_JJ
adaptor_NN
proteins_NNS
that_WDT
recruit_VBP
src_NN
homology_NN
-LRB-_-LRB-
SH_NN
-RRB-_-RRB-
2_CD
domain-containing_JJ
intracellular_JJ
molecules_NNS
to_TO
the_DT
cell_NN
membrane_NN
via_IN
tyrosine-based_JJ
signaling_NN
motifs_NNS
._.

We_PRP
describe_VBP
here_RB
a_DT
novel_JJ
molecule_NN
of_IN
this_DT
group_NN
termed_VBN
SIT_NN
-LRB-_-LRB-
SHP2_NN
interacting_NN
transmembrane_JJ
adaptor_NN
protein_NN
-RRB-_-RRB-
._.

SIT_NN
is_VBZ
a_DT
disulfide-linked_JJ
homodimeric_JJ
glycoprotein_NN
that_WDT
is_VBZ
expressed_VBN
in_IN
lymphocytes_NNS
._.

After_IN
tyrosine_NN
phosphorylation_NN
by_IN
src_NN
and_CC
possibly_RB
syk_JJ
protein_NN
tyrosine_NN
kinases_NNS
SIT_NN
recruits_VBZ
the_DT
SH2_NN
domain-containing_JJ
tyrosine_NN
phosphatase_NN
SHP2_NN
via_IN
an_DT
immunoreceptor_NN
tyrosine-based_JJ
inhibition_NN
motif_NN
._.

Overexpression_NN
of_IN
SIT_NN
in_IN
Jurkat_NN
cells_NNS
downmodulates_VBZ
T_NN
cell_NN
receptor_NN
-_:
and_CC
phytohemagglutinin-mediated_JJ
activation_NN
of_IN
the_DT
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
-LRB-_-LRB-
NF-AT_NN
-RRB-_-RRB-
by_IN
interfering_VBG
with_IN
signaling_NN
processes_NNS
that_WDT
are_VBP
probably_RB
located_JJ
upstream_JJ
of_IN
activation_NN
of_IN
phospholipase_NN
C_NN
._.

However_RB
,_,
binding_NN
of_IN
SHP2_NN
to_TO
SIT_NN
is_VBZ
not_RB
required_VBN
for_IN
inhibition_NN
of_IN
NF-AT_NN
induction_NN
,_,
suggesting_VBG
that_IN
SIT_NN
not_RB
only_RB
regulates_VBZ
NF-AT_NN
activity_NN
but_CC
also_RB
controls_VBZ
NF-AT_NN
unrelated_JJ
pathways_NNS
of_IN
T_NN
cell_NN
activation_NN
involving_VBG
SHP2_NN
._.

